Notice of annual general meeting in Swedish Orphan Biovitrum AB (publ)
(Thomson Reuters ONE) -
The shareholders in Swedish Orphan Biovitrum AB (publ), Reg. No. 556038-9321,
are hereby summoned to the annual general meeting (the "Meeting"), to be held on
Friday 26 April 2013 at 4.00 p.m. in Wallenbergsalen, at Kungliga
Ingenjörsvetenskapsakademien (IVA), Grev Turegatan 16, Stockholm, Sweden.
Participation, etc
Shareholders who wish to attend the Meeting must be recorded in the share
register maintained by Euroclear Sweden AB (the Swedish Central Securities
Depository) on Saturday 20 April 2013, and must notify the company of their
intention to participate in the Meeting not later than on Monday 22 April 2013
at Swedish Orphan Biovitrum's web site www.sobi.com, by mail to Swedish Orphan
Biovitrum AB (publ), "Annual General Meeting", SE-112 76 Stockholm, Sweden or by
phone no. +46 8 697 34 27. Since the Record Date is a Saturday, shareholders
must be recorded in the share register no later than on Friday 19 April 2013.
The notification shall set forth the name, address, telephone number (daytime),
personal/corporate identity number, the number of shares held and, when
applicable, information about representatives and assistants.
As per the day of this notice there are 269,634,858 shares outstanding in the
company, whereof 265,226,598 common shares representing one vote each and
4,408,260 series C shares representing 1/10 vote each, altogether representing
265,667,424 votes. The company holds 4,408,260 own series C shares, which cannot
be represented at the general meeting.
Nominee shares
Shareholders, whose shares have been registered in the name of a nominee through
the trust department of a bank or similar institution, must, in order to be able
to participate in the Meeting, re-register their shares in their own names in
the shareholders' register maintained by Euroclear Sweden AB as per Saturday 20
April 2013. Since the Record Date is a Saturday, the registration must be
completed no later than on Friday 19 April 2013. Shareholders who wish to re-
register their shares in their own name should inform their nominee of such re-
registration well in advance of such date. Such registration may be temporary.
Proxy, etc
Shareholders represented by proxy shall issue a written and dated power of
attorney for the proxy. If the power of attorney is issued on behalf of a legal
entity, a certified copy of a registration certificate for the legal entity
shall be appended. The power of attorney is valid for one year from the issue
thereof or such longer period of time stated in the power of attorney, however
not more than five years. A registration certificate shall evidence the
circumstances prevailing at the day of the Meeting and should not be older than
one year at the time of the Meeting.
The power of attorney in original and, when applicable, the registration
certificate, should be submitted to the company by mail at the address indicated
above well before the Meeting. A proxy form is held available at the company's
web site, www.sobi.com, and will also be sent to shareholders who so request and
who inform the company of their postal address.
Attachment: The complete Notice of annual general meeting in Swedish Orphan
Biovitrum AB (publ)
Contact:
Oskar Bosson, Head of Communications
Phone: + 46 8 697 31 74
About Sobi
Sobi is an international specialty healthcare company dedicated to rare
diseases. Our mission is to develop and deliver innovative therapies and
services to improve the lives of patients. The product portfolio is primarily
focused on inflammation and genetic diseases, with three late stage biological
development projects within hemophilia and neonatology. We also market a
portfolio of specialty and rare disease products for partner companies. Sobi is
a pioneer in biotechnology with world-class capabilities in protein biochemistry
and biologics manufacturing. In 2012, Sobi had total revenues of SEK 1.9 billion
(? 215 M) and about 480 employees. The share (STO: SOBI) is listed on NASDAQ OMX
Stockholm. More information is available at www.sobi.com.
The above information has been made public in accordance with the Swedish
Securities Market Act and/or the Financial Instruments Trading Act. The
information was released for public distribution on 25 March 2013 at 11.00 CET.
Complete notice of AGM in Sobi 2013:
http://hugin.info/134557/R/1687869/553588.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Swedish Orphan Biovitrum AB (publ) via Thomson Reuters ONE
[HUG#1687869]
Unternehmensinformation / Kurzprofil:
Datum: 25.03.2013 - 11:00 Uhr
Sprache: Deutsch
News-ID 242566
Anzahl Zeichen: 5376
contact information:
Town:
Stockholm
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 121 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Notice of annual general meeting in Swedish Orphan Biovitrum AB (publ)"
steht unter der journalistisch-redaktionellen Verantwortung von
Swedish Orphan Biovitrum AB (publ) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
